Narrow Results

Singapore and Korea research institutes to collaborate on biomass-to-chemicals research.

Nobel prize in medicine goes to cell transport discovery.

Tri-institutional Therapeutics Discovery Institute, Inc. launched.

Agilent Technologies collaborates with Florey Institute of Neuroscience and Mental Health.

Quintiles selected by Muscular Dystrophy Association to develop U.S. Disease Registry.

Joslin Diabetes Center forms alliance with John & Johnson Innovation to identify exercise-related drug targets to improve diabetes management.

CLINATEC chairman Alim-Louis Benabid honored for Parkinson's disease work.

AstraZeneca enters co-promotion agreement with Janssen in Japan for innovative prostrate cancer treatment.

Scotland demonstrates its collaborative approach to cell therapy development.

KineMed forms agreement with Amgen to develop kinetic biomarkers of brain proteinopathies.

IMCD group opens its first pharmaceutical laboratory.

Napier Healthcare wins Promising Healthcare IT Company of the Year 2013 Award from Frost & Sullivan Singapore.

AB SCIEX opens R&D center in Singapore; hopes to drive scientific innovation.

Nuvilex acquires rights to use Austrianova's technology.

Cancer Research Technology and Nuevolution collaborate to seek potential cancer drugs.

JPT and Immudex enter partnership.

BIOQuebec and Rx&D join forces to strengthen Canada's biotechnology sector.

Helsinn and Chugai Pharma Marketing enter into agreement.

Berg and Icahn School of Medicine at Mount Sinai announce R&D partnership for drug discovery and development.

NovAliX and Kyowa Hakko Kirin to collaborate on Fragment-Based Drug Discovery Project.

Biopharm GmbH enters into co-research agreement with Merck.

Agilent Technologies to collaborate with University of Queensland on oral cancer research.

PSR-Agility Orphan Drug Development wins ROAR Award for “Best Orphan Drug CRO”.

Vietnam Ministry of Health and Quintiles collaborate to advance clinical trial excellence.

Morflora's TraitUP™ wins Agrow Awards for the Best Novel Agricultural Biotechnology.

Europe's most influential Biomarkers Congress. Manchester, to be held in UK February 2014.

AMSilk founder Professor Thomas Scheibel receives DECHEMA award.

ProJect Pharmaceutics and TUM-Spin-off ImevaX collaborate on development of pharmaceutical formulation for IMX101.

DSM and Tunitas Therapeutics to develop lead allergy therapeutic.

RCSI led EU Consortium receives major funding to develop materials to regenerate cardiac tissue following heart attacks.

Teva and Takeda to research multiple sclerosis treatment in Japan.

AB SCIEX helps accelerate food safety testing in Southeast Asia's largest food producer.

Merck enters into license agreement with the Spanish National Cancer Research Centre.

Agilent Technologies and Nanyang Technological University collaborate on wastewater treatment research.

IBC Life Sciences and ISPE Singapore Affiliate to partner on ISPE Singapore Conference & Exhibition 2014.

Novogen enters global collaboration to drive the development of drugs to treat brain cancer.

Hepalink signs agreement to acquire Scientific Protein Laboratories.

Yasheng Group joint venture with IBC International LLC to form Angel Star Nutrition LLC.

Zynex signs distribution agreement for China market.

Tao Li of China Green Agriculture, receives the honor of “Future Chinese Business Leaders”.

Yingli Green Energy enters joint venture with Datong Coal Mine Group.

Elekta wins public tender to deliver cancer care solutions to China.

Stellar Biotechnologies Announces Collaboration with Amaran Biotechnology, Inc.

TaiGen Biotechnology signed exclusive license agreement with R-Pharm for nemonoxacin (Taigexyn).

Eddingpharm acquires global rights to oncology assets, including Telatinib, from ACT Biotech.

BioLineRx and JHL Biotech to collaborate on Type 1 diabetes antibody treatment.

Bayer and Peking University establish new research center for translational research and drug discovery in Beijing.

Microport Scientific Corporation and Sorin Group sign joint venture agreement for cardiac rhythm management business in China.

Epigenomics signs licensing and supply agreement with Kindstar for Epi proLung in China.

Abcam to open office in Shanghai, China.

Fortis Escorts Heart Institute wins ‘Best Single Specialty Hospital - Cardiology‘ title.

Probiodrug transfers its CDK9 inhibitor program to AstraZeneca.

GE to expand in life sciences with acquisition of strategic assets from Thermo Fisher Scientific.

MD Anderson teams up with Pfizer to advance cancer immunotherapy.

Trovagene and US Oncology Research collaborate on a prospective study for urine-based KRAS testing in patients with metastatic pancreatic cancer.

MedImmune and Immunocore enter immunotherapy agreement to develop novel cancer therapies.

Nodality enters into a strategic collaboration with Johnson & Johnson Innovation in autoimmune diseases.

Knopp Biosciences and NIH to collaborate in evaluating dexpramipexole in patients with hypereosinophilic syndrome.

AMN Healthcare receives top workplace award.

National Cancer Centre Singapore and Clearbridge BioMedics partner to bring circulating tumor cell technology closer to clinic.

Latest updates on soaps, detergents, cosmetics, hair care industry at 4th Emerging HPC Surfactants Markets.

CMT's 11th Phenol/ Acetone & Derivatives Markets in Shanghai, hones in on feedstock costs, excess capacities and more.

A*STAR signs agreement with Nestlé to strengthen food & nutrition R&D in Singapore.

Amorfix enters into agreement with a major global pharmaceutical company for Alzheimer's disease diagnostic.

PHARM Connect Congress- One step before the future.

China Biologic receives GMP certification at its Guizhou Taibang facility.

Hua Medicine's novel glucokinase activator reports positive Phase 1a data for diabetes and initiates Phase 1b trials.

QIAGEN launches QuantiFERON-TB gold in-tube in China to aid tuberculosis control.

AirWare Labs expands manufacturing and sales into China.

Global Partners SillaJen, Transgene and Lee's Pharmaceutical confirm clinical development plan for Pexa-Vec.

Gyros and Tekon Biotech sign distribution agreement.

AstraZeneca and Shenzhen University Health Science Center to collaborate on chronic kidney disease.

Bayer Healthcare to significantly increase production capacity in China.

Boston Scientific receives prestigious Shingo award for operation excellence.

Yakult Honsha and JAXA collaborate on research of the effect by probiotics on human immune function and gut microbiota.

Danziger Innovations and Precision BioSciences collaborate on genome modification in ornamental plants.

Agilent Technologies to host young scientist forums in Asia Pacific to provide platform for rising talents.

AstraZeneca and MRC enter strategic collaboration to create new center for early drug discovery in Cambridge, UK.

Otsuka acquires rights to hematological cancer treatment Dacogen^® from Eisai.

ICON to acquire Aptiv Solutions.

Actavis acquires Silom Medical Company.

CROMA-PHARMA signs a significant distribution agreement with Asia's leading producer of Botulinum Toxins and anti-aging products.

Biametrics successfully finalizes feasibility study with MorphoSys in the area of high-throughput antibody screening.

Proctor & Gamble opens newest research center in Singapore.

Sanford-Burnham and Daiichi Sankyo form alliance to study novel drug targets in cardiovascular metabolic diseases.

Sigma-Aldrich® to launch Austrianova's Cell-in-a-Box® Kit for research use.

ASLAN Pharmaceuticals signs agreement with CSL to develop novel therapy for asthma.

Self-assembling peptides for bone regeneration and drug delivery.

Verisante Technology, Inc. receives the 2014 North American Technology Innovation Leadership of the Year Award from Frost & Sullivan.

Agilent Technologies partners Women in Science, Engineering and Technology in Korea.

Mundipharma and Genewel sign agreement across key global markets for licensing and promotion of Medifoam®.

Janssen collaborates with ViiV Healthcare to develop two-drug single tablet regimen for the maintenance treatment of people living with HIV.

AbbVie opens expanded manufacturing facility in Sligo, Ireland.

AMRI to Acquire Oso Biopharmaceuticals Manufacturing.

Merck to collaborate with Sysmex Inostics on a blood-based RAS biomarker test.

Igenbio establishes direct presence in Japan.

Mesoblast accelerates plans for commercial manufacturing operations in Singapore.

Celerion and Korean Drug Development Fund form collaboration to strengthen early phase clinical research in South Korea.

Dr. Carolyn Mountford, University of Newcastle, Australia receives Agilent Technologies Thought Leader Award.

PHARM Connect – The business summit covering a full industry.

New topics for the Next Generation Sequencing & Single Cell Genomics Asia Congress confirmed.

Registration opened for Oxford Global's 6th Annual Next Generation Sequencing Congress.

Registration opened for Oxford Global's 4th Annual Next Generation Sequencing Asia Congress.

Innovation in Academic Medicine.

Merck Serono awards Grant for Growth Innovation (GGI) for the first time.

National Cancer Institute awards KIYATEC nearly $2M to fund 3D breast cancer, 3D brain cancer micro-tumor development.

Frost & Sullivan honors 2014 Growth, Innovation & Leadership Award winners.

Abcam licenses novel Ceefourin inhibitors of multidrug resistance protein 4 from Australia's Children's Cancer Institute.

Daiichi Sankyo further expands TaNeDS collaborative drug discovery program in Europe.

Veolia Water Technologies South-East Asia to provide advanced water solutions for Tun Razak Exchange Project in Malaysia.

Biocept and Rosetta Genomics collaborate to evaluate microRNAs from circulating tumor cells.

Biocept expands collaboration with MD Anderson Cancer Center.